SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-047968
Filing Date
2024-05-30
Accepted
2024-05-30 16:05:35
Documents
13
Period of Report
2024-05-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0207126-8k_relmada.htm   iXBRL 8-K 37526
  Complete submission text file 0001213900-24-047968.txt   215179

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rlmd-20240524.xsd EX-101.SCH 3012
3 XBRL LABEL FILE rlmd-20240524_lab.xml EX-101.LAB 34767
4 XBRL PRESENTATION FILE rlmd-20240524_pre.xml EX-101.PRE 22715
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0207126-8k_relmada_htm.xml XML 3815
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39082 | Film No.: 241005189
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)